Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06499142 · ClinicalTrials.gov registry record · NA
STP.168 Clinical Study Protocol Parakeet
A NA study of Hyperparathyroidism and Parathyroid Dysfunction, sponsored by Neurovision Medical Products.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06499142: Active NA study of Hyperparathyroidism and Parathyroid Dysfunction, sponsored by Neurovision Medical Products.
NCT06499142 is a NA study of Hyperparathyroidism and Parathyroid Dysfunction that is active but no longer recruiting, run by Neurovision Medical Products. The registered enrollment target is 60 participants, below the 126-participant average among 7 other Hyperparathyroidism trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06499142, a NA study of Hyperparathyroidism and Parathyroid Dysfunction, is active but no longer recruiting, sponsored by Neurovision Medical Products.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
STUDY PURPOSE The purpose of this study is to demonstrate the performance of the Parakeet Rapid Parathyroid Testing Kit by comparing Parakeet results with histopathologic Diagnosis. STUDY OBJECTIVES To demonstrate the positive percent agreement (PPA) and negative percent agreement (NPA) of the Parakeet Rapid Parathyroid Testing kit test results in FNA from excised tissue during parathyroid surgery with Pathologic Diagnosis.
Conditions Studied
Interventions
- DEVICE Parakeet:The Parakeet Rapid Parathyroid Testing Kit is a rapid immunoassay designed to detect Parathormone (PTH) in a test sample.
Study Locations (1)
California
- Ventura County Medical center Santa Paula - Ventura
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-12-18 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
What the registry record for NCT06499142 still lists
NCT06499142 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 126-participant average among 7 other Hyperparathyroidism trials with a reported enrollment target (52% lower).
The record links to 4 conditions, with Hyperparathyroidism appearing as the primary indexed condition, and to 1 intervention - of which Parakeet:The Parakeet Rapid Parathyroid Testing Kit is a rapid immunoassay designed to detect Parathormone (PTH) in a test sample. is the first listed.
NCT06499142 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06499142 about?
NCT06499142 is a clinical study titled "STP.168 Clinical Study Protocol Parakeet". STUDY PURPOSE The purpose of this study is to demonstrate the performance of the Parakeet Rapid Parathyroid Testing Kit by comparing Parakeet results with histopathologic Diagnosis. STUDY OBJECTIVES To demonstrate the positive percent agreement (PPA) and negative percent agreement (NPA) of the Pa...
What is the current status of trial NCT06499142?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-12-18. Estimated completion is 2025-01-31.
What conditions does trial NCT06499142 study?
This clinical trial studies the following conditions: Hyperparathyroidism, Parathyroid Dysfunction, Parathyroid Gland Adenoma, Parathyroid; Anomaly.
What interventions are being tested in trial NCT06499142?
The interventions under investigation include: Parakeet:The Parakeet Rapid Parathyroid Testing Kit is a rapid immunoassay designed to detect Parathormone (PTH) in a test sample. (DEVICE).
Who is sponsoring clinical trial NCT06499142?
This trial is sponsored by Neurovision Medical Products, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06499142 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperparathyroidism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
ACTIVE NOT RECRUITING · NA
-
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
RECRUITING
-
Parathyroidectomy and Mobility Study
RECRUITING
-
Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease
COMPLETED · Phase 3
-
One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study
COMPLETED · Early Phase 1
-
Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI